【参考文献】 1 Balmer A, Zografos L, Munier F. Diagnosis and cttrrent management of retinoblastoma. Oncogene 2006;25(38):534l5349
2 Sheng XL,Wang J,Guo H, et al. Mutations analysis of RB1 gene in Chinese patients with rettinoblastoma. Int J Ophthalmol(Guoji Yanke Zazhi) 2006;6(1):7577
3 Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by doublestranded RNA in caenorhabditis elegans. Nature 1998;391(6669):8068l1
4 Elbashir SM,HaRBorth J,Lendeckel W, et al. Duplexes of 21 nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411(6836):494 498
5 Caplen NJ. A new approach to the inhibition of gene expression. Treends Biotechnol 2002;20(2):4951
6 Parrish S, Fleenor J, Xu S, et al. Functional anatomy of a dsRNA trigger:differential requirement for the two trigger strands in RNA interference. Mol Cell 2000;6(5):10771087
7 Hutvagner G, Zamore PD. RNAi: nature abhors a doublestrand. Curr Opin Genet Dev 2002;12(2):225232
8 Zamore PD, Tuschl T, Sharp PA, et al. RNAi:doublestranded RNA directs the ATPdependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000;101(1):2533
9 Hammond SM, Bernstein E, Beach D, et al. An RNAdirected nuclease mediates posttranscriptioal gene silencing in Drosophila cells. Nature 2000;404(6775):293296
10 Song E, Lee SK, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003;9(3):347351
11 Fu H, Muenzer J, Samulski RJ, et al. Selfcomplementary adenoassociated virus serotype 2 vector:global distribution and broad dispersion of AAVmediated transgene expression in mouse brain. Mol Ther 2003;8(12):911917
12 Stevenson M. Therapeutic potential of RNA interference. N Engl J Med 2004;35(10):17721777
13 Isayeva T, Kumar S, Ponnazhagan S. Antiangiogenic gene therapy for cancer. Int J Oncol 2004;25(12):335343
14 Moreira IS, Fernandes PA, Ramos MJ. Vascular endothelial growth factor(VEGF) inhibitiona critical review. Anticancer Agents Med Chem 2007;7(2):223245
15 Liu WH, Li YZ, Wu YQ. Vaswlar endothelial growth factor and intraocular nevaswlarixation. Int J Ophthalmol(Guoji Yanke Zazhi) 2007;7(6):16811684
16 Wang Q, Liu S. Experimental study of retinoblastoma gene therapy using RNA interference to inhibit VEGF gene expression. Chinese Journal of Optometry & Ophthalmology 2007;9(6):391394
17 Jia RB, Fan XQ, Wang XL, et al. Inhibition of VEGF expression by plasmidbased RNA interference in the retinoblastoma cells. Chinese Journal of Ophthalmology 2007;43(6):493 498
18 Jia RB, Zhang P, Zhou YX, et al. VEGFtargeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma. Ophthalmic Res 2007;39(2):108115
19 Peng HC, He XZ, Fei ZG, et al. Expression of survivin, P16 and Bcl2 proteins in retinoblastoma. Int J Ophthalmol(Guoji Yanke Zazhi) 2005;5(5):939941
20 Coma S, Noe V, Lavarino C, et al. Use of siRNAs and antisnse oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis. Oligonucleotides 2004;14(2):100103
21王国军,胡燕华,李鹏程.survivin和cmyc蛋白在视网膜母细胞瘤中的表达.中华眼科杂志2007;43(6):554556
22 Wang GJ, Hu YH, Li PC. Effects of shRNA targeting survivin on apoptosis of human retinoblastoma cell line Hxorb44 in virto. J Huazhong Univ Sci Technolog 2006;26(5):614 617
23 Zhu HX, Liu S, Zhou CQ, et al. Antiapoptosisgene survivin promotes cell growth and transformation. J Chin Med(Chinese) 2002;82(5):338340
24 Endoh T, Tsuji N, Asanuma K, et al. Survivin enhances telomerase activity via upregulstion of specificity protein 1and cMycmediated human telomerase reverse transcriptase gene transcription. Exp Cell Res 2005;305(2):300311
25 Motoyamal S, LadinesLlave CA, Luis Villanueva S, et al. The role of human papilloma virus in the molecular biology of cervical carcinogensis. Kobe J Med Sci 2004;50(12):919
26 Ha PK, Califano JA. The role of human papillomavirus in oral carcinogensis. Crit Rev Oral Biol Med 2004;15(4):188196
27 Orjuela M, Castaneda VP, Ridaura C, et al. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: An atternative mechan7sm for tumor development. Clin Cancer Res 2000;6:4010 4016
28 Yamato K, Yamada T, Kizaki M, et al. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer. Cancer Gene Ther 2008;15(3):140153
29 Yoshinouchi M, Yamada T, Kizaki M, et al. In vitro and in vivo
growth suppression of human papillomavirus 16positive cervical cancer cells by E6 siRNA. MolTher 2003;8(5):762768
30 Wong S,Weber JD. Deacetylation of the retinoblastoma tumor suppressor protein by SIRT1. Biochem J 2007;407(3):451 460
31 Yang H, Liu FT, Cui DX, et al. Effect of blocking BRCAA1 gene with siRNA on proliferation of MCF7 cells and expression of RB gene. Chinese Journal of Cancer Biotherapy 2006;13(3):181184
32 Shen J, Samul R, Silva R, et al. Suppression of ocular neovascularization with siRNA targeting VEGF receptor1. Gene Ther 2006;13(3):225234
上一页 [1] [2] [3] |